Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 504 6082390

Research Article - Biomedical Research (2017) Volume 28, Issue 7

High miRNA-221 expression is associated with poor overall survival in patients with non-small cell lung cancer

Objective: The objective of this study was to investigate miRNA-221 expression in non-small cell lung cancer (NSCLC) and to determine the correlation between miRNA-221 expression and overall survival.

Methods: Clinical data pertaining to 151 NSCLC patients who underwent complete tumor resection surgery between January 2012 and December 2015 were retrospectively analyzed, and miRNA-221 expression was detected via quantitative reverse transcription polymerase chain reaction (qRT-PCR). The relationship between miRNA-221 expression and patient clinical data, including overall survival (OS), was analyzed.

Results: The expression level of miRNA-221 was significantly higher in NSCLC tissues than in adjacent non-tumor tissues (P<0.05). Significantly higher miRNA-221 expression levels were observed in patients ≥ 50 years of age and with advanced disease (P<0.05). Univariate Cox regression analysis showed that clinical stage (OR=1.97, 95%CI: 1.14-2.67), pathological type (OR=2.55, 95% CI: 1.77-5.12), tumor size (OR=1.34, 95% CI: 1.01-2.14) and miRNA-221 expression (OR=3.08, 95% CI: 1.76-6.31) were risk factors for shorter OS. Multivariate Cox regression analysis showed that clinical stage (OR=3.35, 95%CI: 1.67-5.05), tumor size (OR=2.02, 95%CI: 1.03-3.24) and miRNA-221 expression (OR=2.58, 95%CI: 1.41-64.85) were independent risk factors for shorter OS. The median OS time in the low miRNA-221 expression group was 41 months (95% CI: 36.22-45.78), which was significantly higher than that in the high miRNA-221 expression group (25 months, 95%CI: 5.85-35.15, P=0.011).

Conclusion: Our data indicate that higher miRNA-221 expression levels are associated with shorter OS in patients with NSCLC and that miRNA-221 may be a molecular marker of patient prognosis in NSCLC.

Author(s): Ya Liu, Jing Wang

Abstract Full Text PDF